PAGE2B
gene geneOn this page
Also known as CT16.5
Summary
PAGE2B (PAGE family member 2B, HGNC:31805) is a protein-coding gene on chromosome Xp11.21, encoding Putative G antigen family E member 3 (Q5JRK9).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 22 total — 1 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_001015038
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31805 |
| Approved symbol | PAGE2B |
| Name | PAGE family member 2B |
| Location | Xp11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CT16.5 |
| Ensembl gene | ENSG00000238269 |
| Ensembl biotype | protein_coding |
| Entrez | 389860 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000374971, ENST00000374974, ENST00000879400
RefSeq mRNA: 1 — MANE Select: NM_001015038
NM_001015038
CCDS: CCDS35304
Canonical transcript exons
ENST00000374971 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001614752 | 55076034 | 55076125 |
| ENSE00001615427 | 55077399 | 55077524 |
| ENSE00001657034 | 55076569 | 55076677 |
| ENSE00001799352 | 55075030 | 55075114 |
| ENSE00001919701 | 55078782 | 55078909 |
Expression profiles
Bgee: expression breadth ubiquitous, 122 present calls, max score 95.62.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3790 / max 254.5753, expressed in 23 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196453 | 0.2836 | 21 |
| 196454 | 0.0955 | 11 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.62 | gold quality |
| right testis | UBERON:0004534 | 94.68 | gold quality |
| testis | UBERON:0000473 | 93.87 | gold quality |
| left testis | UBERON:0004533 | 93.74 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.89 | gold quality |
| blood | UBERON:0000178 | 71.13 | gold quality |
| monocyte | CL:0000576 | 68.55 | gold quality |
| leukocyte | CL:0000738 | 66.21 | gold quality |
| granulocyte | CL:0000094 | 59.14 | gold quality |
| bone marrow | UBERON:0002371 | 58.79 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 57.62 | gold quality |
| right uterine tube | UBERON:0001302 | 56.08 | gold quality |
| spleen | UBERON:0002106 | 54.86 | gold quality |
| right lung | UBERON:0002167 | 50.81 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 50.35 | gold quality |
| skin of abdomen | UBERON:0001416 | 49.15 | gold quality |
| apex of heart | UBERON:0002098 | 49.05 | gold quality |
| right lobe of liver | UBERON:0001114 | 48.88 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 48.44 | gold quality |
| zone of skin | UBERON:0000014 | 47.75 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 47.52 | gold quality |
| small intestine | UBERON:0002108 | 47.51 | gold quality |
| skin of leg | UBERON:0001511 | 46.97 | gold quality |
| left ovary | UBERON:0002119 | 46.83 | gold quality |
| bone marrow cell | CL:0002092 | 46.45 | silver quality |
| ovary | UBERON:0000992 | 46.16 | gold quality |
| popliteal artery | UBERON:0002250 | 46.16 | gold quality |
| tibial artery | UBERON:0007610 | 46.13 | gold quality |
| right ovary | UBERON:0002118 | 46.01 | gold quality |
| substantia nigra | UBERON:0002038 | 44.88 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 758.23 |
| E-ANND-3 | no | 1.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting PAGE2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-520A-5P | 99.35 | 66.72 | 1632 |
| HSA-MIR-525-5P | 99.35 | 66.85 | 1615 |
| HSA-MIR-488-5P | 99.28 | 68.12 | 821 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
Cross-species orthologs
0 orthologs
Paralogs (22): PAGE1 (ENSG00000068985), PAGE4 (ENSG00000101951), XAGE2 (ENSG00000155622), PAGE5 (ENSG00000158639), XAGE3 (ENSG00000171402), XAGE5 (ENSG00000171405), GAGE2A (ENSG00000189064), PAGE3 (ENSG00000204279), XAGE1A (ENSG00000204379), XAGE1B (ENSG00000204382), GAGE1 (ENSG00000205777), GAGE12G (ENSG00000215269), GAGE10 (ENSG00000215274), GAGE12E (ENSG00000216649), GAGE12J (ENSG00000224659), GAGE12H (ENSG00000224902), GAGE12D (ENSG00000227488), PAGE2 (ENSG00000234068), GAGE12F (ENSG00000236362), GAGE12C (ENSG00000237671), GAGE13 (ENSG00000274274), GAGE2E (ENSG00000275113)
Protein
Protein identifiers
Putative G antigen family E member 3 — Q5JRK9 (reviewed: Q5JRK9)
Alternative names: Prostate-associated gene 2B protein
All UniProt accessions (2): Q5JRK9, Q5JRL0
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GAGE family.
RefSeq proteins (1): NP_001015038* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008625 | GAGE_fam | Family |
| IPR031320 | GAGE | Domain |
Pfam: PF05831
UniProt features (4 total): chain 1, region of interest 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JRK9-F1 | 62.21 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 97
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 6 (showing top):
chrXp11, MIR5582_3P, MIR4477A, MIR3180_5P, HAY_BONE_MARROW_ERYTHROBLAST, SU_HO_CONV_CENT_CHONDROSARCOMA_LEUKOCYTE_C3_SKELETAL_PROGENITOR_LIKE_CELL
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
202 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PAGE2B | VCF2 | Q5XKR9 | 543 |
| PAGE2B | CPXCR1 | Q8N123 | 485 |
| PAGE2B | MAGEB10 | Q96LZ2 | 478 |
| PAGE2B | MAGEB2 | O15479 | 477 |
| PAGE2B | AIDA | Q96BJ3 | 447 |
| PAGE2B | PABIR2 | Q7Z309 | 434 |
| PAGE2B | MTRNR2L10 | P0CJ77 | 419 |
| PAGE2B | SPANXA1 | Q9NS26 | 400 |
| PAGE2B | DCAF4L1 | Q3SXM0 | 397 |
| PAGE2B | CT45A3 | P0DMU6 | 395 |
| PAGE2B | PAGE1 | O75459 | 392 |
| PAGE2B | ITIH6 | Q6UXX5 | 380 |
| PAGE2B | GAGE4 | P0DSO3 | 377 |
| PAGE2B | DUSP21 | Q9H596 | 371 |
| PAGE2B | SPANXD | Q9BXN6 | 371 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PAGE2B | CRMP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SFSWAP | U2SURP | psi-mi:“MI:0914”(association) | 0.350 |
| CACNA2D3 | GPAA1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (5): PAGE2B (Synthetic Lethality), PAGE2B (Affinity Capture-MS), CRMP1 (Affinity Capture-MS), PAGE2B (Affinity Capture-MS), PAGE2B (Affinity Capture-MS)
ESM2 similar proteins: A1L429, A6NDE8, A6NER3, A6NGK3, O41801, O55777, O60829, O75459, O76087, P03204, P04611, P06937, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P18804, P22421, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q2T9P9, Q3KST0, Q4V321, Q4V326, Q5JRK9, Q5JUK9, Q6AY45, Q6I7R5, Q6IPX3, Q6NT46, Q7Z2X7, Q8AIH8, Q8CCT4
Diamond homologs: O75459, Q5JRK9, Q5JUK9, Q7Z2X7, Q8WTP9, Q8WWM1, Q96GT9, Q96GU1, A6NGK3, A1L429, A6NDE8, A6NER3, O76087, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, Q13066, Q13069, Q13070, Q4V321, Q4V326, Q6NT46, Q9UEU5, Q9HD64
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 13 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3377333 | NM_000032.5(ALAS2):c.-15-2187T>C | Pathogenic |
| 2500873 | NM_000032.5(ALAS2):c.-15-2188A>G | Likely pathogenic |
SpliceAI
715 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:55076032:A:AG | acceptor_gain | 1.0000 |
| X:55076033:G:GG | acceptor_gain | 1.0000 |
| X:55076122:GATT:G | donor_gain | 1.0000 |
| X:55076126:G:GG | donor_gain | 1.0000 |
| X:55076565:TTAG:T | acceptor_loss | 1.0000 |
| X:55076673:TCAAG:T | donor_loss | 1.0000 |
| X:55076675:AAG:A | donor_loss | 1.0000 |
| X:55076676:AGGTG:A | donor_loss | 1.0000 |
| X:55076677:GG:G | donor_loss | 1.0000 |
| X:55076678:G:GA | donor_loss | 1.0000 |
| X:55076679:T:A | donor_loss | 1.0000 |
| X:55076684:G:GT | donor_gain | 1.0000 |
| X:55076685:G:T | donor_gain | 1.0000 |
| X:55076686:A:T | donor_gain | 1.0000 |
| X:55076711:G:GA | donor_gain | 1.0000 |
| X:55077394:TTAA:T | acceptor_loss | 1.0000 |
| X:55077396:A:AG | acceptor_gain | 1.0000 |
| X:55077396:AAG:A | acceptor_gain | 1.0000 |
| X:55077396:AAGG:A | acceptor_gain | 1.0000 |
| X:55077397:A:AG | acceptor_gain | 1.0000 |
| X:55077397:A:AT | acceptor_loss | 1.0000 |
| X:55077397:AG:A | acceptor_gain | 1.0000 |
| X:55077397:AGG:A | acceptor_gain | 1.0000 |
| X:55077398:G:A | acceptor_gain | 1.0000 |
| X:55077398:G:GG | acceptor_gain | 1.0000 |
| X:55077398:GGG:G | acceptor_gain | 1.0000 |
| X:55077478:G:GT | donor_gain | 1.0000 |
| X:55077479:G:T | donor_gain | 1.0000 |
| X:55077518:G:GT | donor_gain | 1.0000 |
| X:55077520:AGCAG:A | donor_loss | 1.0000 |
AlphaMissense
726 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:55076045:A:C | S2R | 0.722 |
| X:55076047:T:A | S2R | 0.722 |
| X:55076047:T:G | S2R | 0.722 |
| X:55076046:G:T | S2I | 0.642 |
dbSNP variants (sampled 300 via entrez): RS1000027015 (X:55076466 A>G,T), RS1000089300 (X:55066566 T>TA), RS1000156857 (X:55062984 T>G), RS1000251873 (X:55066992 G>A), RS1000260422 (X:55033009 T>C), RS1000397393 (X:55063977 T>A), RS1000452185 (X:55071394 T>C), RS1000757188 (X:55046800 T>C), RS1000846062 (X:55044597 C>G), RS1000889611 (X:55044792 A>G), RS1001024121 (X:55035344 G>A,C), RS1001092401 (X:55035638 A>G), RS1001146981 (X:55046249 G>T), RS1001207718 (X:55045212 C>G), RS1001365586 (X:55067553 C>T)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:300751
GenCC curated gene-disease
Mondo (1): X-linked sideroblastic anemia 1 (MONDO:0020721)
Orphanet (1): X-linked sideroblastic anemia (Orphanet:75563)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003983_18 | Male-pattern baldness | 8.000000e-13 |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C536761 | X-linked sideroblastic anemia (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Decitabine | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): androgenetic alopecia, X-linked sideroblastic anemia 1